Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Petersen

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|April 28, 2022
Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta VariantCharlotte B Acharya, John Schrom, Anthea M Mitchell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based TestingGenay Pilarowski, Carina Marquez, Luis Rubio, et al.
Viruses|August 26, 2022
Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East AfricaEmma Pujol-Hodge, Jesus F Salazar-Gonzalez, Deogratius Ssemwanga, et al.
Public Health Reports (Washington, D.C. : 1974)|July 6, 2023
San Francisco's Citywide COVID-19 Response: Strategies to Reduce COVID-19 Severity and Health Disparities, March 2020 Through May 2022Darpun D Sachdev, Maya Petersen, Diane V Havlir, et al.
The Lancet. HIV|October 12, 2024
Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extensionMoses R Kamya, Laura B Balzer, James Ayieko, et al.
BMJ (Clinical Research Ed.)|May 24, 2020
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort studyJoseph A Lewnard, Vincent X Liu, Michael L Jackson, et al.
The Lancet. HIV|September 14, 2025
Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa: a cost-effectiveness modelling analysisAndrew N Phillips, Matthew D Hickey, Starley B Shade, et al.
Health Equity|January 12, 2022
High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx CommunityJamie Naso, Susy Rojas, James Peng, et al.
Plos One|January 30, 2020
The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural UgandaCarina Marquez, Mucunguzi Atukunda, Laura B Balzer, et al.
Journal of the International AIDS Society|January 10, 2018
Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan AfricaDelphine Perriat, Laura Balzer, Richard Hayes, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|April 28, 2022
Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta VariantCharlotte B Acharya, John Schrom, Anthea M Mitchell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based TestingGenay Pilarowski, Carina Marquez, Luis Rubio, et al.
Viruses|August 26, 2022
Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East AfricaEmma Pujol-Hodge, Jesus F Salazar-Gonzalez, Deogratius Ssemwanga, et al.
Public Health Reports (Washington, D.C. : 1974)|July 6, 2023
San Francisco's Citywide COVID-19 Response: Strategies to Reduce COVID-19 Severity and Health Disparities, March 2020 Through May 2022Darpun D Sachdev, Maya Petersen, Diane V Havlir, et al.
The Lancet. HIV|October 12, 2024
Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extensionMoses R Kamya, Laura B Balzer, James Ayieko, et al.
BMJ (Clinical Research Ed.)|May 24, 2020
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort studyJoseph A Lewnard, Vincent X Liu, Michael L Jackson, et al.
The Lancet. HIV|September 14, 2025
Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa: a cost-effectiveness modelling analysisAndrew N Phillips, Matthew D Hickey, Starley B Shade, et al.
Health Equity|January 12, 2022
High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx CommunityJamie Naso, Susy Rojas, James Peng, et al.
Plos One|January 30, 2020
The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural UgandaCarina Marquez, Mucunguzi Atukunda, Laura B Balzer, et al.
Journal of the International AIDS Society|January 10, 2018
Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan AfricaDelphine Perriat, Laura Balzer, Richard Hayes, et al.
Pageof 10